Progressive stage transition does mean getting better: a further test of the Transtheoretical Model in recovery from alcohol problems by Heather, Nick et al.
PROGRESSIVE STAGE TRANSITION DOES MEAN GETTING BETTER:
A FURTHER TEST OF THE TRANSTHEORETICAL MODEL IN RECOVERY FROM
ALCOHOL PROBLEMS
Nick Heather,
Johannes Hönekopp
&
David Smailes
on behalf of the UKATT Research Team
School of Psychology & Sport Sciences,
Northumbria University
Correspondence to: Nick Heather, Division of Psychology, Northumbria University, Newcastle upon
Tyne, NE1 8ST, UK (email: nick.heather@unn.ac.uk)
2ABSTRACT
Aims To test two central assumptions of the Transtheoretical Model (TTM) regarding recovery from
alcohol problems: (1) individuals making a forward transition from pre-action to action stages will
show greater drinking improvements than those remaining in pre-action stages ; and (2) individuals
remaining in pre-action stages will not demonstrate improvements in drinking outcomes.
Design and setting Large, multi-centre, RCT of treatment for alcohol problems (UKATT).
Measurements Stage of change, drinks per drinking day (DDD) and percentage days abstinent (PDA)
at baseline, three months and 12 months follow-up.
Findings In support of TTM assumption 1, improvements in drinking outcomes were consistently
greater among clients who showed a forward stage transition (d = 0.68) than among those who did
not (d = 0.10). Two tests of assumption 2 showed a significant improvement in drinking outcomes in
non-transition groups, inconsistent with the TTM, one test showed a significant deterioration and
the other showed equivalent drinking outcomes across time. An explanation is offered why, under
the relevant assumption of the TTM, clients in non-transition groups showed small changes in
drinking outcomes.
Conclusions In contrast to a previous study by Callaghan and colleagues, our findings largely support
the TTM account of recovery from alcohol problems in treatment. The discrepancy can be explained
by the use in our study of a more reliable and valid method for assigning stage of change.
Keywords Alcohol problems, UKATT, treatment, Transtheoretical Model, stage of change, stage
transitions
3INTRODUCTION
Using data from Project MATCH [1], Callaghan, Taylor and Cunningham [2] recently tested two
central assumptions of the Transtheoretical Model (TTM) of behaviour change [3] regarding
movement through the stages of change posited by this model in the process of recovery from
alcohol problems. In the TTM, stages of change describe the stages through which a person moves
in an intentional effort to resolve an addictive disorder, with each stage representing a set of specific
tasks the person must address to make progress [3,4]. From “precontemplation” through
“contemplation”, “preparation” and “action” to “maintenance”, the person is assumed to pass from
one stage to the next, with the “relapser” re-entering the cycle at either the precontemplation or
contemplation stages. In addition to stages of change, the TTM includes other central constructs.
Processes of change facilitate movement through the stages and represent change principles
deriving from various theories of psychotherapy [5]; levels of change, ranging from
symptom/situational to intrapersonal, assume that individuals are in different stages of change with
respect to different problem areas [5].
While popular among clinicians and many researchers in the addictions field, the TTM has been
criticised [6-10]. Although the full TTM is wider than the concept of the stages of change, it is this
component of the model that has attracted most of the popularity and the criticism. Also, the
findings reported by Callaghan and colleagues [2] concern only one implication of the stage of
change construct, albeit the crucial implication that movement from pre-action to action stages
should be related to changes in the behaviour of interest.
The two TTM assumptions tested by Callaghan et al. were: “(i) individuals making a forward
transition to the action-oriented stages (i.e., preparation/action) will manifest greater drinking
improvements than their counterparts remaining in the pre-action stages (i.e., precontemplation,
contemplation); and (ii) individuals remaining in the pre-action stages across time will not
demonstrate clinically relevant improvements in drinking outcomes” (p.1588). These assumptions
4were tested in data from both the aftercare and outpatient arms of Project MATCH and on two
primary outcome variables – Percent Days Abstinence (PDA) and Drinks per Drinking Day (DDD),
generating eight tests of predictions from the stage of change construct.
Six of these eight tests failed to support the TTM. Treated individuals who had progressed to action-
oriented stages did not manifest greater improvements in drinking behaviour than those remaining
in pre-action stages; individuals remaining in pre-action stages did show statistically significant and
clinically important improvements in drinking behaviour. The authors concluded that “our findings
challenge not only the criterion validity associated with stage movement in the TTM account of
alcoholism recovery, but also recent TTM-based substance abuse treatment approaches which
systematically promote forward stage transition as a primary clinical goal and marker of therapeutic
success” (p.1588).
Data from the United Kingdom Alcohol Treatment Trial (UKATT) [11] provided an opportunity to
replicate the findings reported by Callaghan and colleagues [2]. We were able to use the same
dependent measures of treatment outcome and essentially the same the method of analysis as the
earlier study. However, there were two unavoidable differences. First, Callaghan and colleagues
conducted independent sets of analyses on each of the two arms of Project MATCH (aftercare and
outpatient) whereas UKATT had only one arm. However, in UKATT stage of change was measured on
three occasions – baseline, three and twelve month follow-ups –enabling us to conduct two sets of
analyses on stage of change transitions, ie, from baseline to three month follow-up and from three
to twelve month follow-up.
Secondly, the way in which stage of change was measured differed between the two studies. Project
MATCH used an alcohol-specific version of the University of Rhode Island Change Assessment
(URICA) [12] but, instead of allocating participants to stages of change, predicted drinking outcomes
by a baseline readiness score calculated by summing contemplation, action and maintenance
subscale scores and subtracting the precontemplation subscale score [13,14]. The Callaghan et al.
5study used an approximation of stage status based on dividing readiness scores in each arm of the
Project MATCH sample into tertiles corresponding roughly to precontemplation, contemplation and
preparation/action stages of change [15]. In this way, shifts in stage status from pre to post
treatment could be examined. In UKATT, stage of change was assessed by the Readiness to Change
Questionnaire [Treatment Version] (RCQ[TV] [16,17] as described below.
METHOD
Overview of data source: United Kingdom Alcohol Treatment Trial (UKATT)
UKATT was a pragmatic, multi-centre, randomised controlled trial with open follow-up at three
months after entry and blind follow-up at twelve months. Two treatment modalities were
compared: an adaptation of Motivational Enhancement Therapy (MET) [18] scheduled for three
sessions and Social Behaviour and Network Therapy (SBNT) [19] scheduled for eight sessions. Main
treatment outcomes, an economic evaluation, the results of tests of client-treatment matching
hypotheses and UKATT procedures, including recruitment of participants, screening,
inclusion/exclusion criteria, randomisation, follow-up arrangements and details of treatments and
therapists were reported earlier [11, 20, 21, 22].
A total of 742 clients entered the trial (MET = 422; SBNT = 320). 74.1% were male, 95.6% White and
mean age was 41.6 years (sd=10.1). 10.0% had a university degree or equivalent, 35.7% had no
qualifications of any kind and only 34.8% were in full-time employment. 54.1% were in a current
relationship. The sample showed a moderate to severe level of dependence [23] and a slightly above
average level of alcohol-related problems for a British treatment sample [24]. Follow-up rates were
93% at three months and 83% at twelve months.
Key measures
Drinking: PDA and DDD
As in Project MATCH [13], PDA and DDD were the primary outcome variables in UKATT and were
derived from Form 90 [25]. It has been debated whether clients who are totally abstinent at follow-
6up should be assigned a DDD value of zero [1, 13] or regarded as missing on this variable [11, 26]. As
we wished to replicate Callaghan and colleagues’ analysis, we followed them in using the former
procedure here. As in the earlier report, however, we carried out a supplementary analysis in which
DDD was calculated by excluding clients abstinent at follow-up. These tests showed the same
pattern as those reported in the Results section below and will not be commented on further.
We used values of PDA and DDD from three time-points - baseline, three and twelve months follow-
up. Thus we conducted two sets of analyses on two TTM assumptions, one set on the transition from
baseline to three months stage of change and another on the transition from three months to
twelve months stage of change. This resulted in eight separate tests.
Stage of change: Readiness to Change Questionnaire [Treatment Version] (RCQ[TV])
Stage of change was assessed by the RCQ[TV], a version of the original RCQ [27) adapted for
individuals receiving treatment for alcohol problems. We used the improved, 12-item version of the
instrument based on an analysis of UKATT data [17]. The RCQ[TV] gives subscale scores for three
stages of change – precontemplation, contemplation and action – with each subscale represented by
four items. Respondents are asked to what extent they agree or disagree with each item on a 5-
point Likert scale. Each item is scored between -2 (strongly disagree) and +2 (strongly agree) and
scores on each subscale therefore range between -8 and 8. Respondents are assigned to a stage of
change according to the subscale showing the highest score, with ties being decided in favour of the
stage farthest along the cycle of change.
Sample used in the current study
As in Callaghan et al.’s procedure, we confined the analysis to clients in pre-action stages (ie,
precontemplation or contemplation) either at baseline or three month follow-up. In both cases,
clients making a transition from pre-action to the action stage were assigned to a transition group,
while those remaining in pre-action stages were assigned to a non-transition group. For the baseline
to three month follow-up comparisons 290 clients with non-missing data on drinking variables were
7available in pre-action stages (N=173 in the transition group and 117 in the non-transition group)
and for the three to twelve month comparisons 141 clients with non-missing data were available in
pre-action stages (N=49 in the transition group and 92 in the non-transition group).
Analytical issues
Statistical analysis
To test predictions from the TTM assumption 1, we conducted four ANCOVAs with transition group
versus non-transition group as the independent variable. DDD at three months, DDD at twelve
months, PDA at three months and PDA at twelve months were dependent variables. Each analysis
used a single covariate: DDD at baseline, DDD at three months, PDA at baseline or PDA at three
months. This ANCOVA approach is more powerful than ANOVA with repeated measures [28,29].
TTM assumption 1 predicts that DDD would be lower for clients in the transition group than for
those in the non-transition group after DDD at the earlier time-point had been considered as a
covariate; TTM assumption 1 also predicts that PDA would be higher for clients in the transition
group than for those in the non-transition group after PDA at the earlier time-point had been
considered as a covariate.
Following recent guidelines [30], we also report effect sizes (Cohen’s d) for changes in drinking
outcomes. Here, positive effect sizes indicate an amelioration of drinking outcomes over time while
negative effect sizes indicate a worsening. Effect sizes derived from test statistics may conflate the
magnitude of an effect and its homogeneity across participants [31] and to avoid this we computed
d directly from means and standard deviations.
Statistical hypothesis testing usually seeks to demonstrate that there is a difference between means.
Clearly, this strategy cannot be applied to TTM assumption 2 which states that clients remaining in
pre-action stages across time will not show clinically relevant improvements in drinking outcomes. If
we wish to demonstrate that two groups do not meaningfully differ, a test of equivalence is needed
[32]. In a first step, one decides which maximal deviation between group means is regarded as
8practically irrelevant. Such a decision is always somewhat arbitrary but we used d = |0.2|as a
criterion. That is, we regard a difference in PDA or DDA of one fifth of a standard deviation or less
over time as clinically irrelevant. A test of equivalence establishes if an observed difference between
two groups is significantly smaller than the criterion (d = |0.2|in our case); therefore, a significant
result indicates equivalence. If a difference in drinking outcome observed over time is greater than d
= |0.2|, this speaks directly against equivalence and no further testing of equivalence is required
[32]. However, in this case we tested whether drinking outcomes had changed over time by using a
paired-samples t test.
Consideration of covariates
We did not include treatment modality as a covariate in the above analyses (or any variable other
than the level of the dependent variable at the earlier time-point) for similar reasons to those stated
by Callaghan et al. [2]. First, there is no theoretical reason to believe that the relationship between
stage of change transitions over time and outcome of treatment should vary according to the type of
treatment received. Secondly, there was very little difference in the UKATT data between outcomes
from the two types of treatment studied [11] and no client-treatment matching effects involving
readiness to change or stage of change [21]. Similar theoretical and empirical considerations apply
to other variables that might have been considered as covariates in the analyses reported here.
RESULTS
RCQ[TV] subscale scores
Table 1 shows means and standard deviations of RCQ[TV] subscale scores at three time-points,
together with values for Cronbach’s alpha [32] in each case. These scores are reported for all
participants with valid scores at each time-point.
TABLE 1 ABOUT HERE
9Stage of change assignment
Table 2 shows numbers of clients assigned to each of three stages of change at three month follow-
up given their stage assignment at baseline. Also shown in Table 2 are numbers of clients assigned to
each stage at twelve month follow-up given their stage of change at three months.
TABLE 2 ABOUT HERE
Testing assumption 1: forward transition from pre-action stages to the action stage marks
improvement in drinking
Baseline vs. three months follow-up
DDD. Descriptive statistics for DDD at baseline and three month follow-up can be found in Table 3.
The ANCOVA revealed a significant main effect of forward transition on DDD at month three after
controlling for the effect of DDD at baseline (F1, 287 = 24.0, p < .001). This clearly supports the TTM
prediction. Improvement in the transition group (d = 0.67) was considerably larger than
improvement in the non-transition group (d = 0.26), see Figure 1.
TABLE 3 ABOUT HERE
FIGURE 1 ABOUT HERE
PDA. Descriptive statistics for PDA at baseline and three month follow-up can be found in Table 3.
The ANCOVA revealed a significant main effect of forward transition on PDA at month three after
controlling for the effect of PDA at baseline (F1, 287 = 38.7, p < .001). Again, this clearly supports the
TTM prediction. Improvement in the transition group (d = 0.86) was much larger than improvement
in the non-transition group (d = 0.24), see Figure 2.
FIGURE 2 ABOUT HERE
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Three months vs. twelve months follow-up
DDD. Descriptive statistics for DDD at three and twelve months follow-ups can be found in Table 3.
The ANCOVA revealed a significant main effect of forward transition on DDD at month twelve after
controlling for the effect of DDD at month three (F1, 138 = 7.6, p = .007). This is fully in line with the
TTM prediction; improvement in the transition group (d = 0.32) was larger than improvement in the
non-transition group (d = 0.03), see Figure 3.
FIGURE 3 ABOUT HERE
PDA. Descriptive statistics for PDA at three and twelve months follow-up can be found in Table 3.
The ANCOVA revealed a significant main effect of forward transition on PDA at month twelve after
controlling for the effect of PDA at month three (F1, 138 = 34.7, p < .001). This is again in line with the
TTM prediction; substantial improvement in the transition group (d = 0.46) is contrasted with a
worsened outcome in the non-transition group (d = -0.22), see Figure 4.
FIGURE 4 ABOUT HERE
Integration of results
When effect sizes for changes in drinking outcomes over time were weighted for sample size and
averaged across both dependent variables (DDD and PDA) and across both time-spans (baseline to
three month follow-up and three to twelve month follow-up), we found d = 0.68 for clients showing
a forward transition and d = 0.10 for clients who did not show a forward transition.
Testing assumption 2: no improvement in drinking in the absence of forward stage transition
Baseline vs. three month follow-up
Descriptive statistics for both DDD and PDA at baseline and three months follow-up in the non-
transition group are shown in Table 3. For clients who did not show forward transition from baseline
to three months follow-up, a decrease in DDD from baseline to month three was observed (d = 0.26).
Because this was larger than our criterion for equivalence (d = |0.2|), it follows that DDD outcomes
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were not equivalent [32]. An additional paired-samples t test revealed that the improvement in DDD
was significantly larger than zero (t116 = 3.7, p < .001). Similarly, the observed increase in PDA from
baseline to month three (d = 0.24) was larger than our criterion for equivalence (d = |0.2|). An
additional paired-samples t test revealed that the improvement in PDA was significantly larger than
zero (t116 = 2.6, p < .001). These results go against TTM assumption 2 (see Figures 1 & 2).
Three month vs. twelve month follow-up
Descriptive statistics for both DDD and PDA at three and twelve months follow-up in the non-
transition group are shown in Table 3. The change observed in DDD from months three to twelve (d
= 0.03) was smaller than our criterion for equivalence (d = |0.2|). Consequently, we ran a test for
equivalence [32] which proved to be significant (z = 1.93, p = .027). Thus, DDD at months three and
twelve can be seen as equivalent, supporting the TTM prediction (see Figure 3).
For the same clients, a decrease in PDA was observed between follow-ups at month three and
month twelve (d = -0.22, see Figure 4). As this was larger than our criterion for equivalence (d =
|0.2|), it follows that PDA outcomes were not equivalent [32]. An additional paired-samples t test
revealed that the observed deterioration in drinking outcome was significantly larger than zero (t91 =
2.0, p = .049). Interpretation of this finding is discussed below.
Investigating changes in drinking in the non-transition groups
The three observed changes in drinking outcomes in the non-transition groups run against TTM
predictions. To investigate these changes further, we tested the hypothesis that degree of change in
drinking would be related to changes in pre-action readiness to change viewed as a continuous
measure. We first calculated pre-action readiness scores by subtracting the subscale score for
precontemplation from that for contemplation. We then calculated the change in this pre-action
readiness score from baseline to three month follow-up and from three to twelve month follow-up.
Finally, we ran correlations (product-moment) between these pre-action readiness change scores
and changes in DDD and PDA for both time intervals.
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The resulting correlation coefficients were: baseline to three months follow-up, change in pre-action
readiness x change in DDD, r = .303, N= 117, p < .0005; change in pre-action readiness x change in
PDA, r = -.128, N= 117, p = .085; three to twelve month follow-up, change in pre-action readiness x
change in DDD, r = -.089, N= 92, p = .198; change in pre-action readiness x change in PDA, r = -.313,
N= 92, p = .001. Thus, two correlations were significant at the .001 level or beyond and were in the
direction expected from the hypothesis that improvements in drinking are directly related to
improvements in pre-action readiness to change. One other correlation (with PDA from baseline to
three months) approached significance and was in the expected direction.
DISCUSSION
We attempted to replicate the findings reported by Callaghan et al. [2] but obtained different
results. In testing predictions from the TTM assumption 1 in data from the Project MATCH out-
patient arm and using repeated measures ANOVAs, Callaghan and colleagues failed to find a
significant interaction between transition group and time for either DDD or PDA, thus disconfirming
predictions from the TTM. In data from the Project MATCH after-care arm, however, significant
group x time interactions were found, consistent with predictions from the TTM. Nevertheless,
Callaghan and colleagues concluded that their findings failed to support TTM assumption 1.
While this conclusion might be questioned, our findings regarding assumption 1 unequivocally
support the TTM. All four comparisons between transition and non-transition groups were
significant and confirmed predictions from the TTM. Over both time-periods, participants who had
progressed from pre-action stages to action stages, as allocated by the RCQ[TV], showed significantly
greater improvements in both DDD and PDA than those who had remained in pre-action stages.
When all four effect sizes stemming from these tests were averaged, the effect among clients
showing a forward transition (d = 0.68) was considerably greater than for clients not showing a
forward transition (d = 0.10). Thus, in terms of the title of this article and of its predecessor [2], our
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findings show that progressive stage transition, at least in the way we measured it, does mean
getting better with respect to drinking outcomes.
The interpretation of findings on predictions from TTM assumption 2 is more complicated.
Callaghan et al. reported that all four of their equivalence tests on predictions from this assumption
failed to support the TTM in that clients remaining in pre-action stages showed significant
improvements on drinking outcomes. In our tests using the baseline to three month follow-up data,
we too found significant (but comparatively small) improvements in DDD and PDA among clients
remaining in pre-action stages. These findings go against predictions from the TTM in respect of
assumption 2.
In tests of predictions from assumption 2 in the three to twelve month follow-up data, a test of
statistical equivalence on the DDD outcome showed that there was no change on this variable in the
non-transition group, as predicted by the TTM. However, for PDA, we observed a significant
decrease (ie, a deterioration) in the non-transition group from three to twelve month follow-up.
Since there is nothing in the TTM to suggest that clients remaining in pre-action stages should show
a deterioration in drinking frequency, this finding is clearly inconsistent with the TTM. It is also
inconsistent with Callaghan et al.’s findings advanced in refutation of the TTM since they reported a
significant increase in PDA in both sets of data they examined.
Although not predicted by the TTM, significant improvements in drinking behaviour in the non-
transition groups may not be inconsistent with the model when the way in which stage of change is
measured and allocated is considered. Here, stage of change was decided by the highest RCQ[TV]
subscale score. Accordingly, clients were assigned to the non-transition category because, on the
second occasion, they endorsed precontemplation or contemplation items more strongly than
action items. Although some of these participants showed relatively modest improvements in
drinking, these were clearly not sufficient to bring about a stronger endorsement of action items
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over precontemplation or contemplation items. Similar considerations may apply to the method of
allocating stage of change in the Callaghan et al. study.
Regarding the increase in drinking frequency shown by the non-transition group from three to
twelve months follow-up, this suggests that some individuals, perhaps having made an attempt to
quit or cut down drinking and having failed, may have reverted to the precontemplation stage at the
later follow-up. If so, this implies that decreases in PDA should be correlated with decreases in a
continuous measure of readiness to change confined to pre-action subscale items. Similarly,
increases in DDD should be correlated with decreases in pre-action readiness to change. The same
reasoning applies to improvements in drinking shown in the non-transition group from baseline to
month three assessments. In general terms, these correlations should be apparent, if this hypothesis
is correct, whether or not the non-transition groups as a whole showed significant changes in
drinking behaviour and irrespective of the direction of those group changes. Thus, we should expect
to find significant correlations across clients between changes over time on two measures: pre-
action readiness and DDD or PDA.
This ad hoc hypothesis received some support. When attention was confined to non-transition
groups, two of the four correlations in question were highly statistically significant in the predicted
direction. Although the remaining correlations were not significant, one approached significance in
the expected direction. Thus more evidence is needed to confirm this attempted explanation of
small changes in drinking outcome among individuals who do not show a transition from pre-action
to action stages as measured by questionnaire. It should be noted that a similar phenomenon in
samples in treatment for dependence on marijuana has been reported [34].
Given that our findings are generally supportive of the TTM and therefore stand in contrast to those
reported by Callaghan and colleagues, how can this discrepancy be explained? One explanation
might be that it is due to differences in the samples used. Precontemplators (31% and 35% in the
aftercare arm respectively) were much more frequent in the Callaghan et al. sample than in ours (cf.
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Table 2). It is not clear whether these differences in proportions of precontemplators reflect genuine
differences in levels of readiness to change between samples or whether they arise from differences
in measuring stage of change (see below). Assuming the former, however, there appears to be no
reason why the results of tests of assumptions 1 and 2 from the TTM should depend on the initial
balance of precontemplators and contemplators in the samples; whatever the initial level of stage of
change, participants making a transition to action stages should show greater improvements in
drinking behaviour than those who do not. A similar argument applies to any other differences
between the samples that might be proposed to account for the discrepancy in findings, eg, national
or cultural differences with respect to alcohol consumption and problems or differences in
treatment protocols and regimes.
A more likely explanation concerns measurement techniques and the use of two different
instruments to measure stage of change – the URICA and the RCQ[TV]. The measurement and
allocation of stage of change is clearly a difficult task and no solution to it can be considered perfect.
The algorithm method in which people are allocated to stages on the basis of how recently they
have changed behaviour or how soon they intend to change, used more often in the field of smoking
cessation, has been criticised as arbitrary and illogical [9,10]. Questionnaire methods include the
URICA [12,35], the two forms of the RCQ [16,17,27] and the SOCRATES [36]. In the last-named case,
the three scales identified by factor analysis in the instrument development (called recognition,
ambivalence and taking steps) were not dissimilar from, but not the same as, those described by
DiClemente and Hughes [12].
The development and research applications of the URICA have always been beset by problems in
translating responses to the questionnaire into a valid and reliable designation of stage of change. In
the initial development study by McConnaughy et al. [35] among out-patients receiving
psychotherapy, four distinct stages of change were identified by principal components analysis. A
cluster analysis was then carried out on standardised scores on each of the four scales and resulted
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in an 18 cluster solution, subsequently refined to seven major and two minor client profiles. Using
the same approach to the URICA responses of adults attending outpatient alcoholism treatment,
DiClemente and Hughes [12] found five distinct profiles labelled precontemplation, ambivalent,
participation, uninvolved and contemplation. These profiles appear only loosely related to the
original TTM stages of change upon which the URICA was based. Other studies of the URICA, using a
variety of treatment populations, have reported numbers of cluster profiles ranging between two
and nine [37-41]. Thus there is very little consensus or standardisation in the literature regarding
measurement of stage of change based on the URICA.
The latest method of using URICA responses to allocate stage of change was described by
DiClemente et al. [15]. Researchers first calculated a continuous measure of readiness to change by
adding mean scores on the contemplation, action and maintenance subscales and subtracting the
mean precontemplation subscale score, yielding a continuous score ranging from -2 to +14. In each
of the two Project MATCH treatment arms the sample was then simply divided into three groups of
equal frequency that were then assumed to parallel stages of precontemplation, contemplation and
preparation/action and permitted the assignment of each participant to one of these three stages.
Unresolved issues arising from this approach are discussed by Callaghan and Taylor [42] and more
general problems with the validity of the URICA by Callaghan et al. [34].
DiClemente and colleagues [eg, 43] argue that it is not possible simply to use the highest subscale
score to assign stage of change. However, this is the method used in the RCQ[TV] and it seems to
work satisfactorily in psychometric terms. In the development of the 15-item questionnaire [16]
principal components analysis did not support the inclusion of preparation or maintenance stages.
However, the measurement of precontemplation, contemplation and action stages was shown to be
adequate for research and clinical purposes, although further work was deemed necessary to
strengthen the reliability of the contemplation scale. Significant relationships were found between
allocated stage of change and level of alcohol consumption, length of time in treatment, whether or
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not the participant had previously received treatment for an alcohol problem and outcome of the
current treatment episode. Deficiencies of the contemplation subscale were corrected in the
development of a revised, 12-item edition of the RCQ[TV] based on the large database available
from UKATT [17]. There was ample evidence for the construct validity of the revised instrument and
a strong relationship between stage of change allocation at the end of treatment at three months
follow-up and outcome at twelve months. All this suggests that the RCQ[TV] represents a simpler
and more efficient method for measuring stage of change than the URICA. The highly significant
relationships reported in this article between stage of change assignment and changes in drinking
behaviour are further evidence in themselves for the validity of the RCQ[TV].
In the discussion of their findings disconfirming the TTM, Callaghan and colleagues [1] write: “Our
findings may be due more to the inadequacy of the URICA than faults in the core assumptions of the
Transtheoretical Model, and the use of a refined stage-of-change measure may permit more
definitive conclusions to be drawn about the TTM (pp. 1594-5).” The findings of the present study
support this suggestion and imply that it is the greater reliability and validity of the RCQ[TV]
compared with the URICA, at least with regard to the method of assigning stage status, that is
responsible for the discrepancy between the findings of the present study and that of Callaghan and
colleagues [2].
With regard to the two assumptions under test, a clear confirmation of predictions from assumption
1 is the stronger form of evidence on which to base conclusions about the validity of the TTM since
the model must predict, in any circumstances, that individuals who progress from pre-action to
action stages of change will show greater improvements in drinking behaviour than those who do
not. While predictions from assumption 2 that individuals remaining in pre-action stages will not
show improvements in drinking were not entirely supported in our data, this is less crucial because it
may be possible theoretically to reconcile these observations with the TTM, although the conjecture
advanced here at present lacks sufficient empirical backing. It should be stressed again that the
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improvements shown by participants in the non-transition groups were much smaller and relatively
insignificant compared with those shown in the transition groups and that this observation can only
be interpreted as supporting the TTM.
The support provided here for central assumptions of the TTM has broader implications for an
appraisal of the model and its application in treatment. If, as has been strongly suggested here,
progressive stage transitions are accompanied by the improvements in drinking behaviour that are
the main objective of treatment for alcohol problems, this lends credence to those systematic
treatment approaches [eg, 44-46] in which the promotion of forward movement along the cycle of
change is seen as the primary clinical goal.
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Table 1: Means, standard deviations and values of Cronbach’s alpha for
RCQ[TV] subscale scores at 3 time-points
Baseline 3 months
follow-up
12 months
follow-up
Precontemplation Mean -4.9 -3.3 -2.8
sd 3.1 3.8 4.1
α 0.69 0.76 0.77
N 708 619 540
Contemplation Mean 5.2 3.5 3.1
sd 2.8 3.7 4.2
α 0.64 0.74 0.82
N 714 631 538
Action Mean 4.3 4.6 3.6
sd 3.6 3.4 4.0
α 0.84 0.88 0.87
N 712 626 542
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Table 2: Stage-transition matrices from Baseline to 3 Month Follow-up and
from 3 Month to 12 Month Follow-up
3 Month Follow-up stage of change
Precontemplation Contemplation Action
Baseline stage of change
Precontemplation 0 0 0
Contemplation 4 114 173
Action 5 70 199
12 Month Follow-up stage of change
Precontemplation Contemplation Action
3 Month Follow-up stage of change
Precontemplation 2 3 1
Contemplation 3 86 49
Action 17 91 208
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Table 3: Means (SD) for two drinking outcomes (DDD and PDA) at baseline, 3
and 12 months follow-up for clients who did or did not make a forward stage
transition.
Drinks per Drinking Day (DDD) Percentage Days Abstinent (PDA)
Baseline Month 3 Month 12 Baseline Month 3 Month 12
Forward
transition
baseline to
month 3
Yes 22.5 (12.2) 14.6 (11.2) 25.0 (25.7) 50.9 (34.0)
No 26.0 (14.5) 22.3 (13.5) 21.4 (23.5) 27.8 (29.6)
Forward
transition
months 3
to 12
Yes 19.4 (10.8) 15.5 (13.5) 40.7 (30.8) 56.3 (37.3)
No 24.7 (14.9) 24.2 (14.1) 27.3 (29.4) 21.0 (26.0)
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